ADVISORY, April 20, 2016 (GLOBE NEWSWIRE) --
BeiGene (Nasdaq:BGNE), a global, clinical-stage, research-based biotechnology company focused on targeted and immuno-oncological therapeutics will visit the Nasdaq MarketSite in Times Square to celebrate its recent initial public offering (IPO) on February 3, 2016. With a team of 215+ scientists and staff, BeiGene is advancing a pipeline consisting of three novel oral small molecules and one monoclonal antibody for the treatment of cancer.
In honor of the occasion, John V. Oyler, Founder and Chief Executive Officer and Xiaodong Wang, Ph.D., Founder and Chairman of Scientific Advisory Board, will ring the Opening Bell.
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
Thursday, April 21, 2016 – 9:15 a.m. to 9:30 a.m. ET
BeiGene Media Contact:
Lucy Li, Ph. D.
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:
For photos from ceremonies and events visit our Instagram Page:
For livestream of ceremonies and events visit our YouTube Page:
For news tweets, please visit our Twitter page at:
For exciting viral content and ceremony photos visit Tumblr Page:
A webcast of the Nasdaq Opening Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx
To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.
BeiGene is a global, clinical-stage, research-based biotechnology company focused on molecularly targeted and immuno-oncology cancer therapeutics. With a team of over 215 scientists, clinicians and staff in China, the United States, Australia and Taiwan, BeiGene is advancing a pipeline consisting of novel oral small molecules and monoclonal antibodies for cancer. BeiGene is working to create combination solutions aimed to have both a meaningful and a lasting impact on cancer patients. For more information, please visit our website at www.beigene.com.
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.3 trillion and nearly 17,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.